$COGT
Cogent Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
COGT chart
What traders are saying about $COGT
Latest postsCogent Biosciences, Inc. news
- Cogent Biosciences at Guggenheim conference: launch nears By Investing.com
Investing.com UK ·
- symbol__ Stock Quote Price and Forecast
CNN ·
- Cogent Biosciences, Inc. : H.c. Wainwright Ra
Moomoo ·
- H.C. Wainwright Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $56
Moomoo ·
- HC Wainwright & Co. maintains Cogent Biosciences at Buy, raises price target to $56 from $55
TradingView ·
- Cogent Biosciences Price Target Maintained With a $55.00/Share by HC Wainwright & Co.
Moomoo ·
- Cogent Biosciences, Inc. (COGT) stock price, news, quote and history
Yahoo Finance UK ·
- Stifel Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $45
Moomoo ·
- Cogent Biosciences (COGT) Faces A Valuation Test As FDA Decisions Draw Closer
Yahoo Finance ·
- Cogent Biosciences (COGT) Could Be 89% Undervalued On Wider Third Quarter Losses
Simply Wall St ·
- Cogent Biosciences, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- With $791M in cash and securities, Cogent Biosciences (COGT) posts a wider quarterly loss.
Stock Titan ·
Cogent Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$328.9M | -$255.9M | -$192.4M | -$140.2M |
| Diluted EPS | $-2.16 | $-1.94 | $-1.94 | $-1.73 |
| Total assets (year end) | $937.6M | $327.9M | $313.4M | $300.8M |
| Cash and equivalents (year end) | $312.0M | $98.2M | $53.2M | $139.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cogent Biosciences, Inc.
- Ticker
- COGT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1622229
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
Frequently asked questions
What exchange is Cogent Biosciences, Inc. listed on?
Cogent Biosciences, Inc. trades on the Nasdaq under the ticker symbol COGT.
What industry is Cogent Biosciences, Inc. in?
Cogent Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Cogent Biosciences, Inc. headquartered?
Cogent Biosciences, Inc.'s business address on file with the SEC is in Waltham, MA.
When does Cogent Biosciences, Inc.'s fiscal year end?
Cogent Biosciences, Inc.'s fiscal year ends on December 31.